TECHNOLOGICAL ADDITIVES: antioxidants (tocopherol extracts from vegetable oils (1b306(1)))
Their insurers back them up with endless resources, hoping patients will give up before real accountability is reached
The countries with the most publications were Brazil, Mexico, and Chile
The dosing frequency guide discusses the tradeoffs in detail
EBioMedicine 90 , 104481 (2023)
Burak Altintas, MD, an orthopedist with UTMB, who was not involved in this study, further highlighted the following limitations of the research: The limitations include retrospective design and likely residual confounding despite matching as fracture risk is influenced by many variables that are not reported [] Further, the comparison group is heterogeneous, combining another GLP-1 receptor agonist (dulaglutide) with two mechanistically different weight-loss medications